Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-13

Clinical Trial Update: Efficacy and Safety of Finalgon® Cream Multiple Doses in Acute Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial results for Finalgon Cream at multiple doses show efficacy and safety in acute low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Finalgon Cream (nonivamide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2016-09-13